Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Gastroenterology|December 14, 2023
Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel DiseaseClara Caenepeel, Gwen Falony, Kathleen Machiels, et al.Gut Microbes|May 15, 2025
Virome drift in ulcerative colitis patients: faecal microbiota transplantation results in minimal phage engraftment dominated by microvirusesDaan Jansen, Sara Deleu, Clara Caenepeel, et al.Inflammatory Bowel Diseases|May 30, 2014
Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitisMagali de Bruyn, Ingrid Arijs, Willem-Jan Wollants, et al.Computational and Structural Biotechnology Journal|December 23, 2021
Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approachGerard Serrano-Gómez, Luis Mayorga, Iñigo Oyarzun, et al.Gut|December 25, 2012
Butyricicoccus pullicaecorum in inflammatory bowel diseaseVenessa Eeckhaut, Kathleen Machiels, Clémentine Perrier, et al.Gut|May 22, 2016
Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBDJoão Sabino, Sara Vieira-Silva, Kathleen Machiels, et al.Gut|February 10, 2017
A microbial signature for Crohn's diseaseVictoria Pascal, Marta Pozuelo, Natalia Borruel, et al.Ebiomedicine|January 6, 2020
Mucosal microbial load in Crohn's disease: A potential predictor of response to faecal microbiota transplantationGuillaume Sarrabayrouse, Stefania Landolfi, Marta Pozuelo, et al.The American Journal of Gastroenterology|February 18, 2011
Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatmentIngrid Arijs, Gert De Hertogh, Kathleen Machiels, et al.Gut|November 2, 2016
Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UCIngrid Arijs, Gert De Hertogh, Bart Lemmens, et al.Pageof 3